Astellas

News

Astellas taps Eko digital stethoscope for heart failure DTx

Astellas has licensed rights to a smart stethoscope device developed by Eko Health, that it will use as part of a digital therapeutic (DTx) approach to heart failure.

News

FDA grants Priority Review of Astellas’ zolbetuximab BLA

Astellas Pharma Inc has announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review of its zolbetuximab Biologics License Application

News

Astellas extends protein degrader drive with Cullgen deal

Astellas has become the latest big pharma to pledge big bucks to a smaller company working on protein degraders, paying $35 million upfront to partner with US start-up Cul

News

Astellas hit by US patent verdict for incontinence drug

A US district court has said that a key patent held by Astellas on its Myrbetriq drug for urinary incontinence is invalid, in a setback to its efforts to defend the blockb

News

Kate helps Astellas double up on XLMTM gene therapy

Astellas’ gene therapy for rare disease X-linked myotubular myopathy (XLMTM) has been hampered by safety concerns, so its decision to license an alternative from start-up

News

And Astellas’ latest drug discovery partner is… Sony?

Astellas Pharma has looked outside of the box for its latest cancer drug development partnership, joining forces with Sony on a project to find new antibody-drug conjugate

Astellas taps Eko digital stethoscope for heart failure DTx

FDA grants Priority Review of Astellas’ zolbetuximab BLA

Astellas extends protein degrader drive with Cullgen deal

Astellas hit by US patent verdict for incontinence drug

Kate helps Astellas double up on XLMTM gene therapy

And Astellas’ latest drug discovery partner is… Sony?

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Astellas

Editor's Picks